Who is a Candidate for GLP-1 Medications
Extended Data Figure 5 A near-atomic resolution model of the hGLP-1rGLP-1RG s complex
Medical supervision helps confirm candidacy, guide dosing, monitor side effects, protect nutrition intake and adjust treatment when needed
In the SURPASS-2 study, the three doses of tirzepatide (5, 10, and 15 mg once weekly) were tested with the GLP-1RA semaglutide (1 mg once weekly) as a comparator in patients not optimally controlled on monotherapy with metformin (71)
The benefits of weight loss with tirzepatide are compounding, as an individual loses weight, they will experience a wide range of physical and mental health benefits
Thyroid Cancer Risk: Patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)